Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06072482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Name: A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — clinical trial record (NCT06072482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorAmgen

Started2024-02-07

View on ClinicalTrials.gov ↗

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Amendment history 1 change detected by DataLookout

2026-04-29

Trial sites expanded: 68 → 76 locations

Trial Details

NCT Number	NCT06072482
Lead Sponsor	Amgen
Conditions	Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment	300 participants
Start Date	2024-02-07
Primary Completion	2036-12-31 (estimated)
Study Completion	2036-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-14